• Tue, October 20, 2015
  • Wed, October 21, 2015
  • Fri, October 23, 2015
  • Thu, October 22, 2015

Mark Breidenbach Initiated (BLUE) at Buy and Held Target at $162 on, Oct 20th, 2015

Mark Breidenbach of Oppenheimer, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $162 on, Oct 20th, 2015.

Mark has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Mark's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mark


  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $143 on, Monday, October 5th, 2015

Like: 👍